130 related articles for article (PubMed ID: 28671269)
21. Decreased expression of STAT5A predicts poor prognosis in osteosarcoma.
Guo Z; Tang Y; Fu Y; Wang J
Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
[TBL] [Abstract][Full Text] [Related]
22. APEX1 gene amplification and its protein overexpression in osteosarcoma: correlation with recurrence, metastasis, and survival.
Yang J; Yang D; Cogdell D; Du X; Li H; Pang Y; Sun Y; Hu L; Sun B; Trent J; Chen K; Zhang W
Technol Cancer Res Treat; 2010 Apr; 9(2):161-9. PubMed ID: 20218738
[TBL] [Abstract][Full Text] [Related]
23. RanBP9/TSSC3 complex cooperates to suppress anoikis resistance and metastasis via inhibiting Src-mediated Akt signaling in osteosarcoma.
Dai H; Lv YF; Yan GN; Meng G; Zhang X; Guo QN
Cell Death Dis; 2016 Dec; 7(12):e2572. PubMed ID: 28032865
[TBL] [Abstract][Full Text] [Related]
24. Prostate-specific membrane antigen: a new potential prognostic marker of osteosarcoma.
Zeng C; Ke ZF; Yang Z; Wang Z; Yang SC; Luo CQ; Wang LT
Med Oncol; 2012 Sep; 29(3):2234-9. PubMed ID: 22009216
[TBL] [Abstract][Full Text] [Related]
25. Expression and prognostic relevance of centromere protein A in primary osteosarcoma.
Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH
Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.
Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
Int J Clin Exp Pathol; 2015; 8(8):9314-9. PubMed ID: 26464682
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors in osteosarcoma. A review of 20 year's experience at the University of Pittsburgh Health Center Hospitals.
Scranton PE; DeCicco FA; Totten RS; Yunis EJ
Cancer; 1975 Dec; 36(6):2179-91. PubMed ID: 1060506
[TBL] [Abstract][Full Text] [Related]
28. The prognostic significance of Src and p-Src expression in patients with osteosarcoma.
Hu C; Deng Z; Zhang Y; Yan L; Cai L; Lei J; Xie Y
Med Sci Monit; 2015 Feb; 21():638-45. PubMed ID: 25725252
[TBL] [Abstract][Full Text] [Related]
29. High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma.
Sun K; Gong C; Peng H; Fang H; Zhou J; Li J; Chen S; Zheng H
Mol Med Rep; 2017 Nov; 16(5):6953-6957. PubMed ID: 28901496
[TBL] [Abstract][Full Text] [Related]
30. [Survival analysis and the effects of prognostic factors in patients treated for osteosarcoma].
Ozger H; Eralp L; Atalar AC; Toker B; Ayan I; Kebudi R; Bağbek S; Başaran M; Ağaoğlu F; Dizdar Y; Bilgiç B
Acta Orthop Traumatol Turc; 2007; 41(3):211-9. PubMed ID: 17876121
[TBL] [Abstract][Full Text] [Related]
31. Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma.
Ma H; Seebacher NA; Hornicek FJ; Duan Z
EBioMedicine; 2019 Jan; 39():182-193. PubMed ID: 30579871
[TBL] [Abstract][Full Text] [Related]
32. Expression of MSH2 and MSH6 on a tissue microarray in patients with osteosarcoma.
Jentzsch T; Robl B; Husmann M; Bode-Lesniewska B; Fuchs B
Anticancer Res; 2014 Dec; 34(12):6961-72. PubMed ID: 25503122
[TBL] [Abstract][Full Text] [Related]
33. A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG.
Flores RJ; Kelly AJ; Li Y; Nakka M; Barkauskas DA; Krailo M; Wang LL; Perlaky L; Lau CC; Hicks MJ; Man TK
Cancer; 2017 Jan; 123(1):144-154. PubMed ID: 27529817
[TBL] [Abstract][Full Text] [Related]
34. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
35. Vasculogenic mimicry: a new prognostic sign of human osteosarcoma.
Ren K; Yao N; Wang G; Tian L; Ma J; Shi X; Zhang L; Zhang J; Zhou X; Zhou G; Wu S; Sun X
Hum Pathol; 2014 Oct; 45(10):2120-9. PubMed ID: 25123071
[TBL] [Abstract][Full Text] [Related]
36. Worse prognosis of osteosarcoma patients expressing IGF-1 on a tissue microarray.
Jentzsch T; Robl B; Husmann M; Bode-Lesniewska B; Fuchs B
Anticancer Res; 2014 Aug; 34(8):3881-9. PubMed ID: 25075009
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma.
Li Z; Jia M; Wu X; Cui J; Pan A; Li L
Diagn Pathol; 2015 Sep; 10():167. PubMed ID: 26377811
[TBL] [Abstract][Full Text] [Related]
38. Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience.
Berlanga P; Cañete A; Salom M; Montalar J; Guasp M; Marco A; Castel V
J Pediatr Hematol Oncol; 2016 Apr; 38(3):176-81. PubMed ID: 26925713
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma.
Urakawa H; Nishida Y; Nakashima H; Shimoyama Y; Nakamura S; Ishiguro N
Clin Exp Metastasis; 2009; 26(8):1005-12. PubMed ID: 19802733
[TBL] [Abstract][Full Text] [Related]
40. Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution Experience.
Berlanga P; Cañete A; Díaz R; Salom M; Baixauli F; Gómez J; Llavador M; Castel V
J Pediatr Hematol Oncol; 2015 Jul; 37(5):e272-7. PubMed ID: 25374283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]